Gene Expression Profiling of Hepatocellular Carcinoma Derived Cancer Stem Like Cell under Hypoxia

다국어 초록 (Multilingual Abstract)

Purpose: Cancer stem like cells (CSCs), with unlimited self-renewal potential and other stem cell characteristics, occur in several cancers including hepatocellular carcinoma (HCC). Although CSCs can initiate tumors, malignant proliferation, relapse and multi-drug resistance, the ways how to activate them still remain unknown. This study aims to evaluate whether CSC acquire tumorigenic characters under tumor hypoxia, analyzed by microarray analysis.
Materials and Methods: CSCs were purified from HCC patients and Affymetrix microarray was used to investigate their gene expressionprofiles. The results were validated by real-time polymerase chain reaction (PCR).
Results: The results of the microarray indicated that 18 genes were up-regulated and 10 genes were down-regulated in CSCs. Severalgenes were identified to be significantly involved in the regulation of CSCs such as HCC. Furthermore, the up-regulated genes were related with metabolism, angiogenesis and hypoxia, whereas the down-regulated genes were related with apoptosis and inflammation.
Conclusion: The results may help to understand the mechanisms of tumor development through CSCs which acquired their distinctivetumorogenic properties by hypoxic stimulation.

참고문헌 (Reference)

1 Ferenci P, "World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective" 19 : 311-317, 2010

2 Gadaleta CD, "Trans-arterial chemoembolization as a therapy for liver tumours: new clinical developments and suggestions for combination with angiogenesis inhibitors" 80 : 40-53, 2011

3 Yagi H, "The role of mesenchymal stem cells in cancer development" 4 : 261-, 2013

4 Kitajima Y, "The critical impact of HIF-1a on gastric cancer biology" 5 : 15-26, 2013

5 Bao B, "Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells" 16 : 1041-1054, 2012

6 Ghoshal S, "STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCC" 5 : 201-203, 2016

7 Pasquier J, "Role of the microenvironment in ovarian cancer stem cell maintenance" 2013 : 630782-, 2013

8 Pugh CW, "Regulation of angiogenesis by hypoxia: role of the HIF system" 9 : 677-684, 2003

9 Hickey MM, "Regulation of angiogenesis by hypoxia and hypoxia-inducible factors" 76 : 217-257, 2006

10 Yamashita T, "Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells" 49 : 1105-1110, 2014

11 Krutovskikh V, "New insights in oncology: epigenetics and cancer stem cells" 15 : 716-722, 2011

12 Choi SH, "Inhibition of tumour angiogenesis and growth by small hairpin HIF-1αand IL-8 in hepatocellular carcinoma" 34 : 632-642, 2014

13 Brooks DL, "ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models" 15 : 26-, 2016

14 Samanta D, "Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells" 111 : E5429-E5438, 2014

15 Otrock ZK, "Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives" 70 : 93-102, 2009

16 Harris AL, "Hypoxia--a key regulatory factor in tumour growth" 2 : 38-47, 2002

17 Heddleston JM, "Hypoxia inducible factors in cancer stem cells" 102 : 789-795, 2010

18 Yeung TM, "Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells" 108 : 4382-4387, 2011

19 Mathonnet M, "Hallmarks in colorectal cancer: angiogenesis and cancer stemlike cells" 20 : 4189-4196, 2014

20 Bar EE, "Glioblastoma, cancer stem cells and hypoxia" 21 : 119-129, 2011

21 SchÖning JP, "Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α" 44 : 153-161, 2017

22 Leake I, "Colorectal cancer: targeting self-renewal of cancer stem cells in colorectal cancer-a future treatment option?" 11 : 75-, 2014

23 Yamashita T, "Cancer stem cells in the development of liver cancer" 123 : 1911-1918, 2013

24 Klonisch T, "Cancer stem cell markers in common cancers-therapeutic implications" 14 : 450-460, 2008

25 Piao LS, "CD133+liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma" 315 : 129-137, 2012

26 Ji N, "Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway" 37 : 14637-14651, 2016

27 Rosa R, "Approaches for targeting cancer stem cells drug resistance" 11 : 1201-1212, 2016

28 Sun HC, "Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives" 130 : 307-319, 2004

29 Semela D, "Angiogenesis and hepatocellular carcinoma" 41 : 864-880, 2004